Jan Černý

4.4k citations
207 papers · 3.3k · 1 hit paper · h-index 30

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
    • Multiple Myeloma Research and Treatments
  • Genetics top 2%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 42
    • Hematopoietic Stem Cell Transplantation 38
    • Chronic Myeloid Leukemia Treatments 20
    • Chronic Lymphocytic Leukemia Research 23
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 14

Jan Černý

192 papers receiving 3.2k citations

Jan Černý's Hit Papers

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 2024 · 117 citations
1170+1Years since publication255075100

Peers

Jan Černý
Comparison fields: 5 of 145
  • Hematology 1.4k
  • Genetics 669
  • Transplantation 61
  • Oncology 551
  • Cardiology and Cardiovascular Medicine 337
Replace Ali Ünal with:
Ali Ünal Türkiye
Werner Rabitsch Austria
Anthony Oakhill United Kingdom
Volker Witt Austria
Sy Ha China
Nelson Hamerschlak Brazil
Thomas Martin United States
Alix Eden Seif United States
Panagiotis D. Tsirigotis Greece
Helene M. Schoemans Belgium
Jan Černý relative to Ali Ünal Türkiye Ali Ünal's profile →
Citations per field
00.5×1.5×2×2.3×
Ali Ünal · 1×
Citations per year

Countries citing papers authored by Jan Černý

Since Specialization
Citations

This map shows the geographic impact of Jan Černý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Černý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Černý more than expected).

Fields of papers citing papers by Jan Černý

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Černý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Černý. The network helps show where Jan Černý may publish in the future.

Co-authors

The 25 scholars most cited alongside Jan Černý, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Černý Line = papers co-authored together Jan Černý links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 207 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1998193
2
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3
Hit paper breakdown →
2024117
3 2014114
4 200097
5 202079
6 201776
7 201267
8 202265
9
Prognostic value of the amount of dysfunctional but viablemyocardium in revascularized patients with coronary arterydisease and left ventricular dysfunction. Investigators of thismulticenter study
199861
10 201860
11 202157
12 200453
13 202052
14 199552
15 200250
16 202049
17 201947
18 201245
19 202045
20 200945

About Jan Černý

Jan Černý is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Rheumatology, having authored 207 papers that have together received 3.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (42 papers), Hematopoietic Stem Cell Transplantation (38 papers), Chronic Lymphocytic Leukemia Research (23 papers), Chronic Myeloid Leukemia Treatments (20 papers), Lymphoma Diagnosis and Treatment (17 papers), Acute Lymphoblastic Leukemia research (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Transplantation: Methods and Outcomes (14 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (669 citations), Transplantation (61 citations), Oncology (551 citations) and Cardiology and Cardiovascular Medicine (337 citations). Jan Černý has collaborated with scholars based in United States, Czechia and Saudi Arabia. Frequent co-authors include Kamal Kant Sahu, Ahmad Daniyal Siddiqui, František Štětka, Lenka Spinarova, Milan Frélich, Peter J. Quesenberry, Roman Štípal, Jana Rubáčková Popelová, Lloyd Hutchinson and Bruce A. Woda. Their work appears in journals such as Transplantation and Cellular Therapy, Blood Advances, Blood, Annals of Hematology and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact